EZH2 inhibitors for treating lymphoma

• 收藏
• 分享

专利权人:

Inc.;Epizyme

发明人:

Keilhack, Heike

申请号：

AU2015277139

公开号：

AU2015277139A1

申请日:

2015.06.17

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

he present invention relates to methods of treating cancer by administering an EZH2 inhibitor or a pharmaceutical composition thereof to the subject in need thereof. The present claims define methods for treating specific subtypes of non-Hodgkin's lymphoma comprising the administration to a subject of EZH2 inhibitors. Preferred EZH2 inhibitors include tazemetostat (EPZ-6438 E7438) and other compounds. Dosage amounts and regimes are also defined.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/